Homology Medicines, Inc. (FIXX) SEC Filing 8-K Material Event for the period ending Monday, June 24, 2019

Homology Medicines, Inc.

CIK: 1661998 Ticker: FIXX

View differences made from one to another to evaluate Homology Medicines, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Homology Medicines, Inc..


Assess how Homology Medicines, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Homology Medicines, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Homology Medicines, Inc. provided additional information to their SEC Filing as exhibits

Ticker: FIXX
CIK: 1661998
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-184386
Submitted to the SEC: Thu Jun 27 2019 4:45:02 PM EST
Accepted by the SEC: Thu Jun 27 2019
Period: Monday, June 24, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit
  3. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: